nfr-logonfr-logo
PROSJEKTBANKEN
Bytt til Norsk språk
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

Tildelt: kr 17,8 mill.

Prosjektperiode: 2024-2028

Sted: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Tildelt: kr 29,6 mill.

Prosjektperiode: 2023-2028

Sted: Oslo og 5 andre

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

The high and growing global burden of cancer urges the need for effective implementation of primary cancer prevention (PCP) programmes targeting modifiable risk factors. However, evidence-based programmes with proven effectiveness under controlled environments often fail when implemented in the r...

Tildelt: kr 1,8 mill.

Prosjektperiode: 2023-2027

Sted: Vestland

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...

Tildelt: kr 3,1 mill.

Prosjektperiode: 2023-2025

Sted: Vestland

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS, the lifetime risk to develop various cancers can be as high as 100%, and patients have a 50% chance of transmitting the disease to their offspring. When un...

Tildelt: kr 3,5 mill.

Prosjektperiode: 2023-2025

Sted: Vestland

CL1-Health

Fostering a European Research Area for Health Research

Fostering a European Research Area for Health Research

Tildelt: kr 15,8 mill.

Prosjektperiode: 2022-2029

Sted: Vestland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Multiomics based analysis of brain-gut axis: A search for gastrointestinal disease phenotypes

An intimate yet less known relation between human brain and gut is rapidly emerging as several recent studies have identified various alterations within brain as a result of gastrointestinal disorders and reported comparable variations in gastrointestinal system due to altered brain outputs. Thes...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2020-2022

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Tildelt: kr 8,6 mill.

Prosjektperiode: 2020-2025

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Living well, dying well. A research programme to support living until the end

Every year around 4 million people die in the EU as a result of chronic disease and illness. Many will die in pain or distress, die alone, and die without appropriate health or social care. How we care for the dying is perhaps the most pressing personal, social and public health issue of the 21st...

Tildelt: kr 3,3 mill.

Prosjektperiode: 2019-2022

Sted: Vestland

H20-ERC-European Research Council

Oral bacteria as determinants for respiratory health

Oral bacteria as determinants for respiratory health

Tildelt: kr 14,4 mill.

Prosjektperiode: 2019-2023

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Tildelt: kr 6,5 mill.

Prosjektperiode: 2018-2024

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Tildelt: kr 9,1 mill.

Prosjektperiode: 2018-2021

Sted: Vestland og 2 andre

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Paediatric Clinical Research Infrastructure Network

Tildelt: kr 0,45 mill.

Prosjektperiode: 2017-2021

Sted: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Tildelt: kr 5,1 mill.

Prosjektperiode: 2016-2019

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Tildelt: kr 2,4 mill.

Prosjektperiode: 2016-2020

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Dynamic hormone diagnostics

Dynamic hormone diagnostics

Tildelt: kr 16,7 mill.

Prosjektperiode: 2015-2020

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Female cancer prediction using cervical omics to individualise screening and prevention

While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (hu...

Tildelt: kr 2,3 mill.

Prosjektperiode: 2015-2020

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Aging Lungs in European Cohorts

Aging Lungs in European Cohorts

Tildelt: kr 4,6 mill.

Prosjektperiode: 2015-2019

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts

Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are transplanted into the...

Tildelt: kr 8,1 mill.

Prosjektperiode: 2015-2019

Sted: Vestland

SECURITY-1.10 Security

Online and Mobile Communications for Emergencies

-

Tildelt: kr 1,5 mill.

Prosjektperiode: 2014-2017

Sted: Hordaland

SECURITY-1.10 Security

Online and Mobile Communications for Crisis Response and Search and Rescue

Online and Mobile Communications for Crisis Response and Search and Rescue

Tildelt: kr 0,87 mill.

Prosjektperiode: 2013-2015

Sted: Hordaland

1